AFP	alpha-fetoprotein
BSC	best supportive care
CCC	cholangiocellular carcinoma
CNI	calcineurin inhibitors
CYA	cyclosporine A
HBV	hepatitis B virus
HCV	hepatitis C virus
HCC	hepatocellular carcinoma
IQR	interquartile range
LT	liver transplantation
MMF	mycophenolate mofetil
MOA	multi-organ affection
MWA	microwave ablation
mTORI	mammalian target of rapamycin inhibitors
NA	nucleos(t)id-analog
PCR	polymerase chain reaction
RFA	radio frequency ablation
RFS	recurrence free survival
rHCC	recurrent hepatocellular carcinoma
RIM	restrictive immunosuppressive management
SOA	single-organ affection
TACE	transarterial chemoembolization